Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiopurine S-methyltransferase pseudogene 1 (TPMTP1) is a pseudogene located on human chromosome 18q, closely related by sequence to the true thiopurine S-methyltransferase (TPMT) gene[2]. Pseudogenes like TPMTP1 do not encode a functional enzyme or protein product and are not involved in substrate metabolism, drug interaction, or disease processes. In contrast, the functional TPMT is responsible for the metabolism of thiopurine drugs and is a clinically relevant pharmacogene[2][6][8]. However, TPMTP1 itself does not serve as a therapeutic target, nor is it implicated in disease or pharmacological intervention. The presence of "pseudogene" in its designation indicates its lack of protein-coding capacity and biological function. *Note*: Queries about TPMTP1 as a therapeutic target are likely based on confusion with TPMT. Only TPMT (not TPMTP1) is biomedically significant as an enzyme with drug interactions and genetic variation impacting clinical care[2][6][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiopurine S-methyltransferase pseudogene 1 (TPMTP1).